5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 49.57▼ | 49.54▼ | 49.54▼ | 49.58▼ | 49.22▲ |
MA10 | 49.57▼ | 49.55▼ | 49.58▼ | 49.41▼ | 49.61▼ |
MA20 | 49.57▼ | 49.58▼ | 49.55▼ | 49.21▲ | 49.90▼ |
MA50 | 49.57▼ | 49.37▼ | 49.44▼ | 49.69▼ | N/A |
MA100 | 49.46▼ | N/A | N/A | N/A | N/A |
MA200 | N/A | N/A | N/A | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.010▼ | -0.021▼ | -0.011▼ | 0.080▲ | N/A |
RSI | 22.224▼ | 41.564▼ | 44.705▼ | 48.935▼ | 40.823▼ |
STOCH | 79.167 | 42.689 | 30.985 | 55.449 | 34.484 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -57.953 | -50.713 |
CCI | -387.946▼ | -376.417▼ | -292.444▼ | 18.183 | -62.375 |
Thursday, May 01, 2025 04:25 AM
Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing no ...
|
Thursday, May 01, 2025 03:35 AM
In one of the largest licensing deals in the Australian biotech industry, Dimerix Limited (ASX: DXB) has sealed an exclusive US licence agreement with USA-based Amicus Therapeutics (Nasdaq: FOLD) for ...
|
Wednesday, April 30, 2025 09:17 PM
Dimerix has entered an exclusive licensing deal with Amicus Therapeutics to commercialise its phase III drug candidate DMX-200 in the ... Read More The post Dimerix inks lucrative US licensing deal ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 49.425 | 49.425 | 49.31 | 49.4111 | 4,938 |
30/04/25 | 49.53 | 49.63 | 49.49 | 49.628 | 18,300 |
29/04/25 | 49.65 | 49.65 | 49.65 | 49.65 | 0 |
28/04/25 | 49.55 | 49.584 | 49.51 | 49.584 | 2,800 |
25/04/25 | 49.44 | 49.88 | 49.44 | 49.6434 | 157,753 |
24/04/25 | 49.39 | 50.15 | 49.29 | 49.60 | 265,700 |
23/04/25 | 49.40 | 49.66 | 49.28 | 49.33 | 56,151 |
22/04/25 | 49.12 | 49.15 | 49.09 | 49.115 | 31,100 |
21/04/25 | 48.94 | 49.22 | 48.886 | 48.996 | 38,600 |
17/04/25 | 49.14 | 49.39 | 49.14 | 49.159 | 32,582 |
|
|
||||
|
|
||||
|
|